Evidence map›Paper›PMID 28808947›Full record

ReviewBiophysical reviews2017

The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.

C G Dos Remedios, S P Lal, A Li, J McNamara, A Keogh, P S Macdonald, R Cooke, E Ehler, R Knöll, S B Marston and 11 more

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Biophysical reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Case Report: Deletion in the 5' untranslated region ofFrontiers in cardiovascular medicine · 2026
    Article
  4. Human mutation · 2026
    Article
  5. Article
  6. Article
  7. The Netherlands Heart Tissue Bank : Strengthening the cardiovascular research infrastructure with an open access Cardiac Tissue Repository.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2023
    Article
  8. Article
  9. Reproducibility and reporting negative data.Journal of molecular and cellular cardiology plus · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Regulation of titin-based cardiac stiffness by unfolded domain oxidation (UnDOx).Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 6 countries.

C G Dos RemediosSydney Heart Bank, Discipline of Anatomy & Histology, University of Sydney, Sydney, Australia. crisdos@anatomy.usyd.edu.au.ORCID 0000-0003-1052-7490
S P LalSydney Heart Bank, Discipline of Anatomy & Histology, University of Sydney, Sydney, Australia.
A LiSydney Heart Bank, Discipline of Anatomy & Histology, University of Sydney, Sydney, Australia.
J McNamaraSydney Heart Bank, Discipline of Anatomy & Histology, University of Sydney, Sydney, Australia.
A KeoghHeart Transplant Unit, St Vincent's Hospital, Sydney, Australia.
P S MacdonaldHeart Transplant Unit, St Vincent's Hospital, Sydney, Australia.
R CookeCardiovascular Research Institute, University of California San Francisco, California, USA.
E EhlerCardiovascular Division, Randall Division of Cell and Molecular Biophysics, London, UK.
R KnöllDepartment of Medicine, Karolinska Institutet, Huddinge, Sweden.
S B MarstonNational Heart and Lung Institute, Imperial College London, London, UK.
J StelzerDepartment of Physiology & Biophysics, Case Western Reserve University, Cleveland, OH, USA.
H GranzierMolecular Cardiovascular Research Program, University of Arizona, Tucson, USA.
C BezzinaDepartment of Experimental Cardiology, Heart Failure Research Center, Amsterdam, The Netherlands.
S van DijkDepartment of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
F De ManDepartment of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
G J M StienenDepartment of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
J OdebergDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
F PonténScience for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.
W A Linke
W Linke *Ruhr University, Bochum, Germany.
J van der VeldenDepartment of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLThe University of Sydney · AUSt Vincent's Hospital Melbourne · AUCase Western Reserve University · USImperial College London · GBKarolinska Institutet · SERuhr University Bochum · DEScience for Life Laboratory · SEUniversity of Arizona · USUniversity of California, San Francisco · USUniversity of Vermont · USUppsala University · SE

Funding

PREVENTIVE CARDIOLOGY ACADEMIC AWARDK07HL001120 · NHLBI · UNIVERSITY OF WASHINGTON · PI VAN CITTERS, ROBERT L. · 1985 to 1987
–
British Heart Foundation PG/11/123/29317British Heart Foundation RG/11/20/29266Medical Research Council G0400153
6 · The paper itself

Abstract

The Sydney Heart Bank (SHB) is one of the largest human heart tissue banks in existence. Its mission is to provide high-quality human heart tissue for research into the molecular basis of human heart failure by working collaboratively with experts in this field. We argue that, by comparing tissues from failing human hearts with age-matched non-failing healthy donor hearts, the results will be more relevant than research using animal models, particularly if their physiology is very different from humans. Tissue from heart surgery must generally be used soon after collection or it significantly deteriorates. Freezing is an option but it raises concerns that freezing causes substantial damage at the cellular and molecular level. The SHB contains failing samples from heart transplant patients and others who provided informed consent for the use of their tissue for research. All samples are cryopreserved in liquid nitrogen within 40 min of their removal from the patient, and in less than 5-10 min in the case of coronary arteries and left ventricle samples. To date, the SHB has collected tissue from about 450 failing hearts (>15,000 samples) from patients with a wide range of etiologies as well as increasing numbers of cardiomyectomy samples from patients with hypertrophic cardiomyopathy. The Bank also has hearts from over 120 healthy organ donors whose hearts, for a variety of reasons (mainly tissue-type incompatibility with waiting heart transplant recipients), could not be used for transplantation. Donor hearts were collected by the St Vincent's Hospital Heart and Lung transplantation team from local hospitals or within a 4-h jet flight from Sydney. They were flushed with chilled cardioplegic solution and transported to Sydney where they were quickly cryopreserved in small samples. Failing and/or donor samples have been used by more than 60 research teams around the world, and have resulted in more than 100 research papers. The tissues most commonly requested are from donor left ventricles, but right ventricles, atria, interventricular system, and coronary arteries vessels have also been reported. All tissues are stored for long-term use in liquid N or vapor (170-180 °C), and are shipped under nitrogen vapor to avoid degradation of sensitive molecules such as RNAs and giant proteins. We present evidence that the availability of these human heart samples has contributed to a reduction in the use of animal models of human heart failure.

Indexed as

Healthy donor human heartsHuman heart failureHuman heart tissue bankReducing the use of animals in research

Identifiers

PMID28808947
PMCPMC5578936
OpenAlexW2746599052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.